
Tilray Brands Investor Relations Material
Latest events

Q3 2025
Tilray Brands
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tilray Brands Inc
Access all reports
Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It offers sativa, indica, and hybrid medical marijuana grown and sold under the Tilray brand; cannabis oils; capsules; and accessories for administration of medical cannabis including oral syringes and syringe applicators. The company also provides Tetrahydrocannabinol, Cannabidiol, Sativa, Indica, Hybrid, CBD Energy Shot; Live Resin Vape Pen Cartridges; and Cannabis oil. Tilray Brands Inc. was incorporated in 2018 and is headquartered in New York, New York.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
TLRY
Country
🇨🇦 Canada